Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Amyris Inc. (NASDAQ: AMRS) shares spiked 19.03 percent to close at $4.44 a share Tuesday. The stock traded between $3.70 and $4.58 on volume 2.48 million shares traded. The company and Kuraray Co., Ltd. announced the expansion and extension of their ongoing collaboration for the commercialization of farnesene-based polymers. Shares of Amyris are down approximately 16.0 percent year-to-date.
Get more information on Amyris free access to the in-depth equity report at: www.FiveStarEquities.com/AMRS
Arrowhead Research Corp. (NASDAQ: ARWR) shares jumped 11.33 percent to close at $18.28 a share Tuesday. The stock traded between $16.36 and $18.87 on volume of 3.54 million shares traded. The company announced that it has completed enrollment in the first cohort of a Phase 2a trial of ARC-520, a treatment for the chronic hepatitis B virus. Shares of Arrowhead Research are up approximately 68.0 percent year-to-date.
Get more information on Arrowhead Research and free access to the in-depth equity report at: www.FiveStarEquities.com/ARWR
The Providence Service Corporation (NASDAQ: PRSC) shares surged 34.37 percent to close at $38.00 a share Tuesday. The stock traded between $28.07 and $38.59 on volume 1.06 million shares traded. The company announced that it has acquired Australian based Ingeus Limited for roughly GBP £35 million. Shares of Providence are up approximately 48.0 percent year-to-date.
Get more information on Providence and free access to the in-depth equity report at: www.FiveStarEquities.com/PRSC
Rubicon Technology, Inc. (NASDAQ: RBCN) shares increased 14.97 percent to close at $12.98 a share Tuesday. The stock traded between $12.18 and $13.04 on volume of 1.68 million shares traded. JP Morgan has upgraded the company's rating to "overweight" from "neutral" and has also raised its price target to $14.00. Shares of Rubicon Technology are up approximately 30.0 percent year-to-date.
Get more information on Rubicon Technology and free access to the in-depth equity report at: www.FiveStarEquities.com/RBCN
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]